Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001140361-15-045654

President & CEO sold 63,209 shares at an average $39.06 ($2,468,633)

  • President & CEO acquired 63,209 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Abdun-Nabi Daniel · President & CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2015-12-23 Exercise or conversion : show line 1 in the form +40,354 $18.90 $762,691 225,722 D
2015-12-23 Sale : show line 2 in the form −40,354 $38.99 $1,573,402 185,368 D
2015-12-24 Exercise or conversion : show line 3 in the form +22,855 $18.90 $431,960 208,223 D
2015-12-24 Sale : show line 4 in the form −22,855 $39.17 $895,230 185,368 D
Open-market sales · 63,209 sh · avg $39.06 · $2,468,633

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-12-23 Exercise or conversion : show line 5 in the form Stock Option −40,354 $18.90 2019-03-09 40,354 22,855 D
2015-12-24 Exercise or conversion : show line 6 in the form Stock Option −22,855 $18.90 2019-03-09 22,855 0 D
Loading xslF345X03/doc1.xml…